# Terumo completes acquisition of Sequent Medical

Terumo Corporation, through its subsidiary MicroVention, completed the acquisition of Sequent Medical, a medical device firm based in Aliso Viejo, CA, for $280 million upfront plus up to $100 million in milestone payments. Sequent developed the WEB Aneurysm Embolization System.

- Type: Acquisition
- Announced: 2016-07-14
- Where: Aliso Viejo, CA, United States
- Value: $280.0M
- Status: completed
- Products: WEB Aneurysm Embolization System
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Terumo](https://endata.com/companies/2811.md) (acquirer)
- [MicroVention](https://endata.com/companies/22671.md) (partner)
- [Sequent Medical](https://endata.com/companies/22672.md) (target)

## Sources

- [terumoneuro.com](https://www.terumoneuro.com/newsroom/press-releases/terumo-corporation-completes-acquisition-of-sequent-medical), 2017-03-07: "We are very pleased to add Sequent Medical, including its outstanding research and development capacity, its unique WEB system and its talented team to the MicroVention family."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.